These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21362684)

  • 21. The use of metformin for women with PCOS undergoing IVF treatment.
    Tang T; Glanville J; Orsi N; Barth JH; Balen AH
    Hum Reprod; 2006 Jun; 21(6):1416-25. PubMed ID: 16501038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities".
    Hourvitz A; Maman E; Brengauz M; Machtinger R; Dor J
    Fertil Steril; 2010 Jul; 94(2):496-501. PubMed ID: 19589517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
    Ye H; Huang G; Pei L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.
    Serour G; Mansour R; Serour A; Aboulghar M; Amin Y; Kamal O; Al-Inany H; Aboulghar M
    Fertil Steril; 2010 Oct; 94(5):1707-12. PubMed ID: 19896654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI.
    Mijatovic V; Florijn E; Halim N; Schats R; Hompes P
    Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):62-5. PubMed ID: 20409633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.
    Detti L; Ambler DR; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
    J Assist Reprod Genet; 2008 May; 25(5):177-81. PubMed ID: 18461435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized decision-making in IVF: calculating the chances of pregnancy.
    van Loendersloot LL; van Wely M; Repping S; Bossuyt PM; van der Veen F
    Hum Reprod; 2013 Nov; 28(11):2972-80. PubMed ID: 23925394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles.
    Ou YC; Lan KC; Huang FJ; Kung FT; Lan TH; Chang SY
    Fertil Steril; 2010 Jan; 93(1):96-100. PubMed ID: 19108823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
    Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
    Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine instillation of diluted seminal plasma at oocyte pick-up does not increase the IVF pregnancy rate: a double-blind, placebo controlled, randomized study.
    von Wolff M; Rösner S; Germeyer A; Jauckus J; Griesinger G; Strowitzki T
    Hum Reprod; 2013 Dec; 28(12):3247-52. PubMed ID: 24045780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.